Key facts
- It has raised $19.1M; the latest was Debt - General ($10.0M) in Mar 2025.
- Notable investors include General Catalyst, BoxGroup, Left Lane Capital, Labcorp Venture Fund, G9 Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Evvy
- ·The full record, as it builds
Funding rounds
No funding rounds for Evvy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evvy
Developer of at-home vaginal microbiome test designed to close the gender health gap and improve female health. The company's test leverages metagenomic sequencing to understand symptoms and risks for critical health challenges, and get personalized reports, enabling women to get insights into their bodies and improve overall health.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 48
- Website
- evvy.com/
- Ownership
- Privately Held (backing)
Evvy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evvy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evvy in its N-PORT filings yet. We sweep new filings monthly.